EWM
TCRT icon

Essex Woodlands Management’s Alaunos Therapeutics TCRT Stock Holding History

Essex Woodlands Management’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-18,003
Closed -$13.7M – 10
2014
Q4 		$13.7M Sell
18,003
-430
-2% -$228K 4.27% 5
2014
Q3 		$7.13M Hold
18,433
– – 2.6% 6
2014
Q2 		$10.3M Hold
18,433
– – 2.13% 7
2014
Q1 		$11.8M Hold
18,433
– – 3% 6
2013
Q4 		$11.3M Hold
18,433
– – 5.69% 5
2013
Q3 		$9.72M Hold
18,433
– – 6.42% 5
2013
Q2 		$5.41M Buy
+18,433
New +$5.12M 4.15% 5

Other funds holding TCRT

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Essex Woodlands Management's TCRT Position: Q1 2015 in Review

Essex Woodlands Management sold out of Alaunos Therapeutics (TCRT) in Q1 2015, closing a stake of 18,003 shares — an estimated $13.7M sold.

Essex Woodlands Management first reported a position in TCRT in Q2 2013 and held it in 7 quarters. The position peaked at $13.7M in Q4 2014. 128 funds tracked by Wall St. Rank hold TCRT as of Q1 2015.

  • Essex Woodlands Management reported no remaining Alaunos Therapeutics position as of Q1 2015 after selling out during the quarter.
  • Essex Woodlands Management sold 18,003 Alaunos Therapeutics shares in Q1 2015, an estimated $13.7M.
  • Essex Woodlands Management first reported a position in Alaunos Therapeutics in Q2 2013 and held it in 7 quarters.
  • Essex Woodlands Management's Alaunos Therapeutics position peaked at $13.7M in Q4 2014.
  • 128 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q1 2015.

Based on Essex Woodlands Management's 13F filing for Q1 2015, filed 8 May 2015.